Will NGS-Based Cancer Tests Become Routine?

Jon Roffman

Jon Roffman, Managing Principal, ZS Associates, discusses whether NGS-based cancer tests will become routine with Debra Patt, MD, MPH, MBA, Vice President, Texas Oncology.

Related Videos

CAR-T Center and Patients

How Can a CAR-T Center Get Established and Effectively Treat Patients

Manufacturers and CAR-T

How Can Manufacturers Help Institutions Prepare for CAR-T Therapies

Future of CAR-T therapies

Will Tomorrow's CAR-T Therapy Innovations Solve Today's Challenges

Next-Gen Sequencing

Next-Gen Sequencing is Transforming Oncology Practices

Hazards of Misinformation

Oncology Clinical Trials

What Lies Ahead

Future of Cancer Care